RecruitingNCT06277362
Peripheral Extreme Revascularization in "No-option" Patiens With Chronic Limb Threatening Ischemia
"Arterial-Venous Reversal Flow in "No-option" Chronic Limb-threating Ischemia (CLTI) Patients"
Sponsor
EndoCore Lab s.r.l.
Enrollment
50 participants
Start Date
Jan 31, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
The objective of the study is to evaluate early safety and effectiveness of the percutaneous deep foot venous arterialization performed in clinical practice, in an unselected population of patients with "no-option" CLTI.
Eligibility
Min Age: 18 Years
Inclusion Criteria5
- Age ≥18 years
- Patient has signed an approved informed consent form
- All patients, with non-revascularizable critical lower limb ischemia defined on the basis of 2 previous unsuccessful Percutaneous Transluminal Angioplasty (PTA) attempts or on severe Medial Artery Calcification (MAC)/Small Artery Disease (SAD) stage.
- Patient with Critical Limb Ischaemia, Rutherford category, 5 (minor tissue loss) or 6 (major tissue loss) with active trophic lesions
- Ejection Fraction > 30%
Exclusion Criteria3
- Subject no able to perform the follow up or other factors making clinical follow-up difficult
- Patients with critical ischaemia of the lower limbs revascularizable by bypass or angioplasty, critical ischaemia characterised by rest pain (Rutherford class ≤ 4)
- Ejection Fraction < 30%
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(9)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06277362
Related Trials
Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System
NCT073353411 location
Comparison of a Lithotripsy vs Standard Preparation Followed by Stenting With Supera Stent in Femoropopliteal Lesions
NCT061121711 location
Ultrasound Perfusion Estimation for Assessment of Peripheral Arterial Disease
NCT069525431 location
Handgrip Training in Patients With Peripheral Artery Disease
NCT036637772 locations
SELUTION4BTK Trial
NCT0505529748 locations